After launching a vision-loss awareness effort last month, Allergan has teamed up with its first celebrity spokesman: Common.

Sen. Bernie Sanders lays into TV network execs for their “lack of coverage” on drug pricing.

Johnson & Johnson, pushing empathy as a tool to connect with consumers, is using product-paired apps as a way to do well by doing good.

Drugmakers spend big money and lots of time crafting the names of their new products. In the end, after all that work, they’re prime candidates for spoofing.…

Novartis is taking its digital efforts up a notch with new tools designed to help multiple sclerosis patients understand their illness.

AbbVie’s Humira finished the last month of 2016 in much the same way it did most of the year—as the No. 1 national TV ad spender among pharma brands.

Pharma companies spent $2.2 billion last year on TV ads for their 20 top brands, and nine of the biggest spenders each went over $100 million, according to…

The FDA’s promotional enforcement squad wasn’t very active in 2016—until December, that is. This month, they've cited six drugmakers, more than half the…